The Top Line

Available every Friday morning, The Top Line podcast will recap the biggest news and why it matters—from mergers and marketing to drug R&D and device development.

Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b
Podcast

Patent expirations push biopharma industry toward a tougher 2026

As patent protections expire and growth slows across the industry, only a handful of drugmakers expect bigger gains in 2026.
The Top Line podcast logo

As AI evolves, the modern R&D lab is changing

Mar 6, 2026 8:47am
Autoimmune CAR-TNavigating the FDAs new regulatory playbook

Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook

Feb 27, 2026 7:45am
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

Trump's tariff threats, measured by manufacturing

Feb 20, 2026 9:30am
Top drug launches of 2026

The biggest potential drug launches of 2026

Feb 6, 2026 8:45am
Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

Biopharma's rebound keeping pace so far

Jan 30, 2026 9:34am